Effexor Plaintiffs Want To Drop 40% Of Suits From MDL
The plaintiffs in multidistrict litigation over Wyeth Pharmaceuticals Inc.'s depression and anxiety drug Effexor have sought to drop some 26 suits targeting the Pfizer unit over the drug's alleged birth defect...To view the full article, register now.
Already a subscriber? Click here to view full article